181 – 190 of 317
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report.
(
- Contribution to journal › Article
- 2009
-
Mark
Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic
(
- Contribution to journal › Article
-
Mark
Thrombin generation assay: a useful routine check-up tool in the management of patients with haemophilia?
(
- Contribution to journal › Article
-
Mark
The plasma concentration of activated protein C appears normal in patients with haemophilia
(
- Contribution to journal › Article
-
Mark
Cumulative incidence of inhibitors: it is influenced by type of replacement therapy in previously treated boys with severe haemophilia A. No
(
- Contribution to journal › Published meeting abstract
-
Mark
Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needs
(
- Contribution to journal › Scientific review
-
Mark
Improved automated VWF:RCo assay for VWF/FVIII concentrates and plasma samples by adjustment of assay reagents, composition and performance parameters
(
- Contribution to journal › Published meeting abstract
-
Mark
The application of bypassing-agent prophylaxis in haemophilia A patients with inhibitors: a meeting report
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Treatment and prevention of acute bleedings in von Willebrand disease--efficacy and safety of Wilate, a new generation von Willebrand factor/factor VIII concentrate.
(
- Contribution to journal › Article
-
Mark
Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens.
(
- Contribution to journal › Article